Cytosorbents (CTSO) Change in Cash (2010 - 2026)

Cytosorbents (CTSO) has reported Change in Cash for 17 consecutive years, with -$400000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Cash rose 71.1% year-over-year to -$400000.0; the trailing twelve-month figure through Jun 2026 stood at -$5.8 million (down 79.96% YoY), and the FY2025 full-year result was -$2.0 million, up 65.94% from the prior year.
• Change in Cash improved to -$400000.0 in Q2 2026 per CTSO's latest filing, from -$1.4 million in the prior quarter.
• Across five years, Change in Cash topped out at $5.6 million in Q4 2023 and bottomed at -$12.9 million in Q2 2022.
• Historically, Change in Cash has averaged -$2.7 million across 5 years, with a median of -$2.5 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Change in Cash slumped 349.73% in 2022, then soared 1465.95% in 2023.
• Over 5 years, Change in Cash stood at -$407672.0 in 2022, then jumped by 1465.95% to $5.6 million in 2023, then plunged by 143.17% to -$2.4 million in 2024, then surged by 46.46% to -$1.3 million in 2025, then jumped by 68.92% to -$400000.0 in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$400000.0, -$1.4 million, and -$1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.